Abstract
The clinical introduction of the so-called ‘targeted therapies’ some 15 years ago has started a new era in the treatment of cancer patients. These drugs hugely increase the possibilities to treat patients based on the genetic mutations of their cancer and therefore hold the promise of ‘personalized medicine’. However, resistance
... read more